Advertisement

Topics

Companies Related to "BioMarker Strategies LLC" [Most Relevant Company Matches] RSS

21:40 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "BioMarker Strategies LLC" found in our extensive corporate database of over 50,000 company records.

Showing "BioMarker Strategies" Companies 1–25 of 690

Extremely Relevant

BioMarker Strategies LLC

BioMarker Strategies is a privately-held molecular diagnostics company founded in 2006 at The Johns Hopkins Science & Technology Park in Baltimore, and now based in Rockville, Maryland. Our mission is to help make personalized medicine more of a reality for patients with solid tumor cancers, by providing powerful new molecular tools and research services t...


Relevant

BioMarker Strategies, LLC

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fresh biopsies or other fresh, unfixed samples such as xenografts or tumorgrafts. SnapPath® can help guide cancer drug development and treatment selection. The Company’s Path...

BioMarker Strategies

BioMarker Strategies (www.biomarkerstrategies.com) is a cancer diagnostics company that is developing a novel biomarker testing system to improve the treatment of cancer. SnapPath™ incorporates an automated and proprietary live-tumor-cell processing device with first-in-class, ex vivo biomarker tests to predict patient response to targeted cancer ther...


ABL, Inc. and Aushon BioSystems

Aushon BioSystems, Inc. is leading the way in protein biomarker discovery, development and analysis. Through the unique combination of proprietary microarray printing, extensive biomarker content and ease-of-use, the Cira™ immunoassay platform is serving leading pharmaceutical companies, contract research organizations and clinical reference laborator...

BiomarkerBase

BiomarkerBase™ (http://www.biomarkerbase.com) includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagnostic (theranostic) test, and every biomarker in an active phase 3 or 4 clinical drug trial. All records in BiomarkerBase™ are linked directly to primary authorities such as ...

Glycemion Strategies, Inc.

Glycemion Strategies, Inc. provides marketing strategies to the pharmaceutical, functional food, nutraceutical and diagnostics industries.

Newport Strategies

Newport Strategies is the industry leader in the collection, validation, analysis and delivery of competitive intelligence concerning the development and manufacture of active pharmaceutical ingredients (APIs) worldwide. Newport Strategies' data and research teams gather, validate and analyze this primary intelligence through a network of hundreds of industry contacts across the globe.Since its fo...

Avantra Biosciences

Avantra Biosciences is a privately held diagnostics company that has pioneered next-generation technology for protein biomarker analysis. Initially focused on oncology, Avantra's integrated system enables scientists and clinicians to perform multiplex biomarker analysis for research use only (RUO) from their lab bench or clinical trial site.

Laurus Strategies

Laurus Strategies is a team of trusted advisers that provides open and honest strategic guidance for organizations of every size. Every expert at Laurus Strategies is driven by a relentless passion to deliver bold solutions that optimize organizational performance and unleash human potential across every phase of the employee lifecycle.

Precision Biomarker Resources, Inc.

Precision accelerates its clients’ research and drug development by working closely with them on targeted biomarker discovery services, including microarray processing, experimental design consultation and data analysis. The team’s expertise, both scientific and technical, enhances every stage of the process, from discovery through preclinical, clinical and post-market studies. The laboratory ...

ApoCell, Inc.

Based in Houston, Texas, ApoCell (www.apocell.com) is a privately-held specialty clinical research company. Founded in 2004, the firm is a leader in molecular biomarker detection and analysis and leverages its expertise in the areas of oncology, diabetes, molecular diagnostics and drug development to measure biomarker signatures in clinical trial subjects....

Stemina Biomarker Discovery Inc.

Stemina Biomarker Discovery was founded in 2007 and is located in Madison, Wisconsin. Stemina is a biomarker discovery company focused on diagnosis and individualized treatment of neurological disorders including autism spectrum disorders. Stemina uses its proprietary metabolomics platform to identify changes in metabolism that can be biomarkers more effec...

Oxford Gene Technology (OGT)

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine. The company has two trading businesses, Biomarker Discovery and Clinical & Genomic Solutions. Biomarker Discovery: OGT delivers tailored biomarker discovery solutions that optimise drug and diagnostic ...

NXG Strategies, LLC

NXG Strategies is a pioneer in identity theft resolution services, and a national authority on identity theft and corporate information breach. Through its international network of marketing partners, NXG helps businesses combat identity theft. NXG evaluates security strategies and designs solutions resulting in consumer acquisition and retention, consumer protection, and Red Flag compliance. ...

Strategies to Overcome and Prevent (STOP) Obesity Alliance

The Strategies to Overcome and Prevent (STOP) Obesity Alliance is a collaboration of consumer, provider, government, labor, business, health insurers and quality-of-care organizations united to drive innovative and practical strategies that combat obesity.

Aushon BioSystems

Aushon BioSystems provides advanced microarray printing technology, robust biomarker content and innovative multiplex immunoassay development and detection services to leading pharmaceutical, biotechnology, academic and diagnostic organizations worldwide. Our unique multiplex immunoassay platform delivers exceptional performance, quality and reliability th...

Aushon BioSystems, Inc.

Aushon BioSystems provides advanced microarray printing technology, robust biomarker content and innovative multiplex immunoassay development and detection services to leading pharmaceutical, biotechnology, academic and diagnostic organizations worldwide. Our unique multiplex immunoassay platform delivers exceptional performance, quality and reliability th...

Sense Proteomic Limited

Sense Proteomic Limited is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise autoantibody biomarkers for cancer and autoimmune diseases. We have developed a novel functional protein array technology which allows thousands of human proteins to be analysed in a single experiment. Our primary focus is on using our technology to discover new...

Fujirebio Diagnostics, Inc.

Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio Holdings, Inc., is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. The company pioneered and introduced the CA125 test, the first FDA-approved ovarian cancer biomarker over 25 years ago. Fujirebio Diagnostics specializes in the clinical development, manufactur...

QDI Strategies Incorporated

The quality and interpretation of the information used in strategy development is critical to building 20/20 insight. That’s why QDI consultants dig deeper than others. We use a proven “discovery research process” including voice of the customer, voice of the market and quantitative models to develop 20/20 insight. Throughout this process we continually address creating and capturing value ...

Ezose Sciences Inc.

Ezose (pronounced ā-zōse) Sciences Inc., based in Pine Brook, NJ, is dedicated to advancing glycomics to improve scientific understanding and healthcare. Ezose’s proprietary GlycanMap® technology platform brings a new dimension to biomarker discovery by enabling glycomics research on a scale comparable to that of genomics and proteomics. Ezose ...

ELM Limited

GOR regularly covers a broad range of subjects including government and regulatory policy, clinical trials and fundamental research trends, marketing strategies, advances in IT, social and health economic aspects and business strategies.

Probably Relevant

Targos Molecular Pathology GmbH

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical application for ethical, economic and regulatory reasons. Targos combines molecular pathology expertise with highly standardized analytics and applies strict project and quality management to provide the in...

QDI Strategies, Inc.

QDI StrategiesDuring the late 1970's and the 1980's, several of the principals of QDI Strategies were at a midsize consulting firm helping clients develop various types of business and marketing strategies. Steve Bassill, the firm's COO, responsible for the firm's operations and theory development, looked at the results the firm and other consulting firms were delivering. Steve found roughly one t...

TopLine Strategies

TopLine Strategies (http://www.toplinestrategies.com) delivers the complete integration and development lifecycle of sales and marketing technologies to corporations and institutions, as well as premier HR consulting and staff augmentation services for the technology sector. TopLine Strategies' practice expertise includes Customer Relationship Management, Enterprise Benefit Enrollment Management, ...


More From BioPortfolio on "BioMarker Strategies LLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks